Cytolytic bradykinin antagonists
US5849863A · kind A · utility
16Cited by
3References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 8, 1995 |
| Grant date | Dec 15, 1998 |
| Priority date | — |
| Expiry date | Sep 8, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K19/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides bradykinin antagonists effective to inhibit cancer cell growth. Also provided are methods of inhibiting lung cancer cell growth by administering a therapeutically effective amount of a dimerized bradykinin antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.